Mammography in New Hampshire: Characteristics of the women and the exams they receive

Journal of Community Health

Volumn 25, Issue 3, 2000, Pages 183-198

  Carney, Patricia A ^b   Goodrich, Martha E ^b   O'Mahony, Deirdre M ^b   Tosteson, Anna N ^b   Eliassen, M Scottie ^b   Poplack, Steven P ^b   Birnbaum, Steven ^a   Harwood, Beth G ^b   Burgess, Karen A ^b   Berube, Brenda T ^b   Wells, Wendy S ^b   Ball, Jeanette P ^b   Stevens, Marguerite M ^b  

^a Parkland Medical Center   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Breast cancer detection; Mammography screening

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SCREENING; DEMOGRAPHY; FAMILY HISTORY; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; RISK FACTOR; UNITED STATES;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ATTITUDE TO HEALTH; BREAST NEOPLASMS; EVALUATION STUDIES; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; NEW HAMPSHIRE; PATIENT COMPLIANCE; REGISTRIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 0034091532     PISSN: 00945145     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005151914471     Document Type: Article

References (44)

1. American Cancer Society. Cancer Facts and Figures-1996. Atlanta, GA: American Cancer Society: Atlanta, GA. Publication number: 96-300M-No. 5008.96.
2. Ernster V, Barclay J, Kerlikowske K, Grandy D, Henderson C. Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 1996; 12:913-8.
3. Choi W, Parker B, Pierce J, Greenberg E. Regional differences in the incidence and treatment of carcinoma in situ of the breast. Cancer Epidem Biomarkers Prev 1996; 4:317-20.
4. Baker LH. Breast Cancer Detection Demonstration Project: Five-year summary report. CA Cancer J Clin 1982; 32:94-225.
5. Shapiro S, Venet W, Strax P, Venet L, Roeser R. Ten to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst 1982; 69:349-55.
6. Verbeek AL, Hendricks JH, Holland R, Mravunac M, Sturmans F, Day NE. Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975-1981. Lancet 1984; 1:1222-4.
7. Tabar L, Fagerberg CJ, Gad A, Baldertorp L, Holmberg LH, Grontoft O. Reduction in mortality from breast cancer after mass screening with mammography. Randomized trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1985; 1:829-32.
8. deKoning HJ, Francheboud J, Boer R, Verbeek AL, Collette HJ, Hendricks JH. Nation-wide breast cancer screening in The Netherlands: Support for breast cancer mortality reduction. Int J Cancer 1995; 60:777-80.
9. Smart CR, Hendrick RE, Rutledge JH, Smith RA. Benefit of mammography screening in women 40-49 years. Cancer 1995; 75:1619-26.
10. Fletcher SW, Black W, Harris R, Rimer BK, Shapiro. Report of the International Workshop on Screening for breast cancer. J Natl Cancer Inst 1993; 85:1644-56.
11. Mettlin CJ, Smart CR. The Canadian National Breast Screening Study. An appraisal and implications for early detection policy. Cancer; Diagnosis Treatment, Research 1993; 72:1461-5.
12. Fletcher SW. Why question screening mammography for women in their forties? Radiol Clin North Am 1995; 33:1259-71.
13. New Hampshire State Cancer Registry, 1993.
14. Chen VW, Wu XC. Cancer in North America, 1990-1994. Volume II: Mortality. Sacramento, CA: North American Association of Central Cancer Registries, 1998.
15. New Hampshire Office of State Planning (September, 1994). 1994 Population Estimates. Concord, NH.
16. Carney PA, Poplack SP, Wells WA, Littenberg B. Development and Design of a Population-Based Mammography Registry: The New Hampshire Mammography Network. Am J Roentgenol 1996; 167:367-72.
17. Ballard-Barbash R, Taplin SH, Yankaskas BC, Ernster VL, Rosenberg RD, Carney PA, Barlow WE, Geller BM, Kerlikowske K, Edwards BK, Lynch CF, Urban N, Chrvala CA, Key CR, Poplack SP, Worden JK, Kessler LG. Breast Cancer Surveillance Consortium: A national mammography screening and outcomes database AmJ Roentgenol 1997; 169:1001-8.
18. Kopans DB, D'Orsi CJ, Adler DED, et al. Breast Imaging Reporting and Data System, 3rd ed. Reston, VA: American College of Radiology, 1998.
19. Jaro MA. Probabilistic Linkage of Large Public Health Data Files. Statistics in Medicine, 1995; 14: 491-8.
20. Burgess, KA, Harwood B, Robinson M, Carney, PA. A Qualitative Study of Mammographers' Participation in a Large Database Research Study. Radiologic Technology 1999; 70(5):453-460.
21. Derby CA, Hume AL, Barbour MM. Correlates of postmenopausal estrogen use and trends through the 1980s in two southeastern New England communities. Am J Epi, 1993; 137:1125-35.
22. Criqui MH, Suarez L, Barrett-Connor E. Postmenopausal estrogen use and mortality. Results from a prospective study in a defined, homogenous community. Am J Epi 1975; 102:209-16.
23. Johannes CB, Crawford SL, Posner JG, McKinlay SM. Longitudinal patterns and correlates of hormone replacement therapy use in middle-aged women. Am J Epi 1994; 140:439-52.
24. Wood AJ. Hormonal treatment of postmenopausal women. NEJM 1994; 330:1062-71.
25. Session DR, Kelly AC, Jewelewicz R. Current concepts in estrogen replacement therapy in the menopause. Fertil Steril 1993; 59:227-84.
26. Felson DT, Zhang Y, Hannon MT, Keil DP, Wilson PW, Anderson JJ. The effect of postmenopausal estrogen therapy on bone density of elderly women. NEJM 1993; 273:199-208.
27. Fantl JA, Cardozo L, McClish DK. Estrogen therapy in the management of urinary incontinence in postmenopausal women: The first report of the hormones and urogenital therapy committee. Obst Gynecol 1994; 83:12-8.
28. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 1995; 273:199-208.
29. Finucane FF, Madans JH, Bush TL, Wolf PH, Kleinman JC. Decrease risk of stroke among postmenopausal hormone users. Arch of Int Med 1993; 153:73-9.
30. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997, 350:1047-59.
31. Colditz GA, Hankinson SE, Hunter DJ. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. NEJM 1995;332:1589-93.
32. Helzlsouer KJ, Couzi R. Hormones and breast cancer. Cancer 1995; Suppl 76:2059-63.
33. Stanford JL, Weiss NS, Voigt LF, Daling JR, Habel LA, Rossing MA. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. JAMA 1995; 274:137-42.
34. Tzingounis V, Cardamakis E, Ginopoulos P, Argiropoulos G. Incidence of benign and malignant breast disorders in women taking hormones (contraceptive pill or hormone replacement therapy). Ca Res 1996; 16:3397-4000.
35. Smith HO, Kammerer-Doak DN, Barbo DM, Sarto GE. Hormone replacement therapy in the menopause: A pro opinion. CA Cancer J Clin 1996; 46:343-63.
36. DiSaia PJ, Grosen EA, Kurosaki T, Gildea M, Cowan B, Anton-Culver H. Hormone replacement therapy in breast cancer survivors: a cohort study. Am J Obstet Gynecol 1996; 176:1494-98.
37. Persson I, Thurfjell E, Bergstrom R, Holmberg L. Hormone replacement therapy and the risk of breast cancer. Nested case-control study in a cohort of Swedish women attending mammography screening. Int J Ca 1997; 72:758-61.
38. Breckwoldt M, Keck C, Karck U. Benefits and risks of homone replacement therapy. J Steroid Biochem Molec Biol 1995; 53:205-8.
39. Mayeaux EJ, Jr, Johnson C. Current concepts in postmenopausal hormone replacement therapy. J Fam Pract 1996; 43:69-75.
40. Laya MB, Gallagher JC, Schreiman JA. Effect of postmenopausal hormone replacement therapy on mammographic density and parenchymal pattern. Radiology 1995; 196:443-47.
41. Stomper PC, Van Voorhis BJ, Ravkinar VA. Mammographic changes associated with post menopausal hormone replacment therapy: A longitudinal study. Radiology 1990; 174:487-90.
42. Leung W, Goldberg F, Zee B, Sterns E. Mammographic density in women on postmenopausal hormone replacement therapy. Surgery 1997; 122:669-74.
43. Staftlas AF, Hoover RN, Brinton LA, Szklo M, Olson DR, Salane M. Mammographic densities and risk of breast cancer. Cancer 1991; 67:2833-8.
44. Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB. Quantitative classification of mammographic densities and breast cancer risk: Results from the Canadian National Breast Screening Study. JNCI 1995; 87:670-5.